| Literature DB >> 16953421 |
S Cassens1, E A Nickel, M Quintel, P Neumann.
Abstract
The serotonin syndrome is caused by a drug-induced increase of the intrasynaptic serotonin concentration. Milder forms of the syndrome may be difficult to diagnose because of the variability of symptoms. Severe forms often rapidly turn into a life-threatening situation, therefore the serotonin syndrome may be a challenge for physicians. We describe the pathophysiology and therapeutic options of the serotonin syndrome and report about a 42-year-old female patient who ingested large amounts of moclobemide, a monoamine oxidase inhibitor, and citalopram, a selective serotonin reuptake inhibitor, for attempted suicide. Within a few hours the patient developed a lethal serotonin syndrome although ICU therapy was initiated immediately.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16953421 DOI: 10.1007/s00101-006-1089-1
Source DB: PubMed Journal: Anaesthesist ISSN: 0003-2417 Impact factor: 1.041